UA27908C2 - Сульфатна сіль n,n-диметил-2-[5-(1,2,4-триазол-1ілметил)-1н-індол-3-іл]етиламіну та/або її сольвати, фармацевтична композиція на її основі, спосіб одержання фармацевтичної композиції і спосіб лікування - Google Patents

Сульфатна сіль n,n-диметил-2-[5-(1,2,4-триазол-1ілметил)-1н-індол-3-іл]етиламіну та/або її сольвати, фармацевтична композиція на її основі, спосіб одержання фармацевтичної композиції і спосіб лікування

Info

Publication number
UA27908C2
UA27908C2 UA94129126A UA94129126A UA27908C2 UA 27908 C2 UA27908 C2 UA 27908C2 UA 94129126 A UA94129126 A UA 94129126A UA 94129126 A UA94129126 A UA 94129126A UA 27908 C2 UA27908 C2 UA 27908C2
Authority
UA
Ukraine
Prior art keywords
indol
triazol
ethylamine
dimethyl
treatment
Prior art date
Application number
UA94129126A
Other languages
English (en)
Inventor
Раймонд Бейкер
Віктор Гіліо Матасса
Кароль Олів
Кендал Джордж Пітт
Девід Едвард Сторі
Леслі Джозеф Стріт
Александр Річард Гіблін
Original Assignee
Мерк Шарп Енд Дом Лімітед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929211903A external-priority patent/GB9211903D0/en
Priority claimed from GB939307306A external-priority patent/GB9307306D0/en
Application filed by Мерк Шарп Енд Дом Лімітед filed Critical Мерк Шарп Енд Дом Лімітед
Publication of UA27908C2 publication Critical patent/UA27908C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
UA94129126A 1992-06-05 1993-05-28 Сульфатна сіль n,n-диметил-2-[5-(1,2,4-триазол-1ілметил)-1н-індол-3-іл]етиламіну та/або її сольвати, фармацевтична композиція на її основі, спосіб одержання фармацевтичної композиції і спосіб лікування UA27908C2 (uk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929211903A GB9211903D0 (en) 1992-06-05 1992-06-05 Pharmaceutical composition
GB939307306A GB9307306D0 (en) 1993-04-07 1993-04-07 Therapeutic agents
PCT/GB1993/001132 WO1993025547A1 (en) 1992-06-05 1993-05-28 The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy

Publications (1)

Publication Number Publication Date
UA27908C2 true UA27908C2 (uk) 2000-10-16

Family

ID=26301005

Family Applications (1)

Application Number Title Priority Date Filing Date
UA94129126A UA27908C2 (uk) 1992-06-05 1993-05-28 Сульфатна сіль n,n-диметил-2-[5-(1,2,4-триазол-1ілметил)-1н-індол-3-іл]етиламіну та/або її сольвати, фармацевтична композиція на її основі, спосіб одержання фармацевтичної композиції і спосіб лікування

Country Status (27)

Country Link
US (1) US5527817A (uk)
EP (1) EP0573221B1 (uk)
JP (2) JP2619197B2 (uk)
KR (1) KR100286411B1 (uk)
CN (1) CN1043532C (uk)
AT (1) ATE165602T1 (uk)
AU (2) AU4337293A (uk)
BG (1) BG61976B1 (uk)
CA (1) CA2097208C (uk)
CZ (1) CZ282060B6 (uk)
DE (1) DE69318212T2 (uk)
DK (1) DK0573221T3 (uk)
ES (1) ES2116411T3 (uk)
FI (3) FI106201B (uk)
HK (1) HK1010050A1 (uk)
HU (1) HUT71403A (uk)
IL (1) IL105847A (uk)
LV (1) LV12210B (uk)
MX (1) MX9303373A (uk)
NO (1) NO307420B1 (uk)
NZ (1) NZ253210A (uk)
RO (1) RO114326B1 (uk)
RU (1) RU2130022C1 (uk)
SG (1) SG50406A1 (uk)
SK (1) SK279211B6 (uk)
UA (1) UA27908C2 (uk)
WO (1) WO1993025547A1 (uk)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2116411T3 (es) * 1992-06-05 1998-07-16 Merck Sharp & Dohme La sal sulfato de un triazol sustituido, composiciones farmaceuticas de la misma y su uso en terapia
EP0840733B1 (en) * 1995-07-11 2001-10-24 Merck & Co., Inc. A triazolylmethyl-indole ethylamine bisulfate salt
ZA965837B (en) * 1995-07-11 1997-01-31 Merck & Co Inc A triazolylmethyl-indole ethylamine bisulfate salt
US6349719B2 (en) 1997-02-24 2002-02-26 Aradigm Corporation Formulation and devices for monitoring the efficacy of the delivery of aerosols
US6192882B1 (en) * 1997-02-24 2001-02-27 Aradigm Corporation Formulation and devices for monitoring the efficacy of the delivery of aerosols
ATE284691T1 (de) 1998-11-02 2005-01-15 Merck & Co Inc Zusammensetzungen aus einem 5ht1b/1d agonisten und einem selektiven cox-2 hemmer zur behandlung von migräne
DK3168218T3 (en) 2001-08-15 2019-01-14 Pharmacia & Upjohn Co Llc Crystalline comprising an L-malic acid salt of N- [2- (DIETHYLAMINO) ETHYL] -5 - [(5-FLUOR-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDE) METHYL] -2,4 -DIMETHYL-1H-PYRROL-3-CARBOXAMIDE FOR USE AS A MEDICINE
WO2006137083A1 (en) * 2005-06-20 2006-12-28 Natco Pharma Limited Improved process for the preparation of rizatriptan benzoate
ES2270717B1 (es) * 2005-08-08 2008-03-01 Ragactives, S.L. Procedimiento para la obtencion de derivados de triptamina.
EP1951713A1 (en) * 2005-11-14 2008-08-06 Matrix Laboratories Ltd Process for the large scale production of rizatriptan benzoate
AU2008259518A1 (en) * 2007-06-04 2008-12-11 Generics [Uk] Limited Novel process
CA3010568C (en) 2016-01-27 2023-10-17 Instar Technologies A.S. Oromucosal nanofiber carriers for therapeutic treatment
WO2024144413A1 (ru) * 2022-12-28 2024-07-04 Общество С Ограниченной Ответственностью "Ферринг Продакшн" Жидкая фармацевтическая композиция для назального введения, содержащая ризатриптан

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1528319A3 (ru) * 1985-07-23 1989-12-07 Глэксо Груп Лимитед (Фирма) Способ получени производных имидазола или их физиологически приемлемых солей
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
DE69026759D1 (de) * 1989-07-03 1996-06-05 Yoshitomi Pharmaceutical Benzazin-Verbindungen und deren pharmazeutische Verwendungen
US5075313A (en) * 1990-09-13 1991-12-24 Eli Lilly And Company 3-aryl-4(3H)quinazolinone CCK antagonists and pharmaceutical formulations thereof
GB9026998D0 (en) * 1990-12-12 1991-01-30 Glaxo Group Ltd Medicaments
SK278998B6 (sk) * 1991-02-01 1998-05-06 Merck Sharp & Dohme Limited Deriváty imidazolu, triazolu a tetrazolu, spôsob i
ES2116411T3 (es) * 1992-06-05 1998-07-16 Merck Sharp & Dohme La sal sulfato de un triazol sustituido, composiciones farmaceuticas de la misma y su uso en terapia

Also Published As

Publication number Publication date
NO307420B1 (no) 2000-04-03
BG99132A (bg) 1995-07-28
IL105847A0 (en) 1993-09-22
JP2972150B2 (ja) 1999-11-08
FI20001776A7 (fi) 2000-08-10
FI20001776L (fi) 2000-08-10
AU659311B2 (en) 1995-05-11
RU94046380A (ru) 1996-12-10
HU9403478D0 (en) 1995-02-28
FI945694L (fi) 1994-12-02
LV12210B (en) 1999-03-20
SG50406A1 (en) 1998-07-20
EP0573221B1 (en) 1998-04-29
US5527817A (en) 1996-06-18
KR950701922A (ko) 1995-05-17
NO944656L (no) 1994-12-02
SK147994A3 (en) 1995-07-11
FI20001777A7 (fi) 2000-08-10
FI106201B (fi) 2000-12-15
NZ253210A (en) 1995-09-26
RU2130022C1 (ru) 1999-05-10
WO1993025547A1 (en) 1993-12-23
EP0573221A1 (en) 1993-12-08
LV12210A (lv) 1999-01-20
MX9303373A (es) 1995-01-31
SK279211B6 (sk) 1998-08-05
CA2097208A1 (en) 1993-12-06
ES2116411T3 (es) 1998-07-16
KR100286411B1 (ko) 2001-04-16
CZ304494A3 (en) 1995-09-13
DE69318212T2 (de) 1998-11-19
FI945694A0 (fi) 1994-12-02
DE69318212D1 (de) 1998-06-04
ATE165602T1 (de) 1998-05-15
CN1089263A (zh) 1994-07-13
CN1043532C (zh) 1999-06-02
IL105847A (en) 1998-09-24
HK1010050A1 (en) 1999-06-11
AU4337293A (en) 1994-01-04
DK0573221T3 (da) 1998-10-07
CA2097208C (en) 2005-02-08
JPH09176155A (ja) 1997-07-08
HUT71403A (en) 1995-11-28
CZ282060B6 (cs) 1997-05-14
BG61976B1 (bg) 1998-11-30
NO944656D0 (no) 1994-12-02
AU3987593A (en) 1993-12-09
RO114326B1 (ro) 1999-03-30
FI20001777L (fi) 2000-08-10
JP2619197B2 (ja) 1997-06-11
JPH0641121A (ja) 1994-02-15

Similar Documents

Publication Publication Date Title
EP0438230A3 (en) Indole-substituted five-membered heteroaromatic compounds
MA21682A1 (fr) Procede de preparation d'agents therapeutiques derives de la quainclidine.
MA23091A1 (fr) Procede de preparation d'agents antiparasitaires .
EA199700251A1 (ru) 5-замещенные-3-(1,2,3,6-тетрагидропиридин-4-ил)- и 3-(пиперидин-4-ил)-1н-индолы и их фармацевтически приемлемые соли и сольваты, фармацевтическая композиция на их основе, способ активации рецепторов 5-нти способ ингибирования нейронной белковой транссудации
ITFI910071U1 (it) Piastra per osso per la porzione distale dell'omero.
HUT71403A (en) The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy
ITRM920688A0 (it) Apparecchio per l'analisi topografica di superfici anatomiche, in particolare della cornea
DE69323759D1 (de) Verwendung von toremifene für die behandlung von sle
ES2162936T3 (es) Tratamiento de la ansiedad.
FI974640L (fi) Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit
FI971127L (fi) 2,4-diaminopyrimidiini-3-oksidin tai jonkin sen suolan käyttö kollageenin kypsymis- ja rakentumishäiriöiden hoitamiseen
IT1274859B (it) Metodo e dispositivo per l'alimentazione pneumatica di pacchetti di sigarette.
FR2641353B1 (fr) Vanne d'arret, en particulier vanne d'arret de regulation, pour canalisations
AU6542896A (en) A triazolylmethyl-indole ethylamine bisulfate salt
MY110795A (en) The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy
FR2673472B1 (fr) Procede pour la mise en evidence d'agglutinats eythrocytaires.
ITMI942673A0 (it) Precesso per la (co) polinerizzazione dell'etilene
FR2783172B1 (fr) Produit contenant du lait d'equides
FR2735948B1 (fr) Structure d'accueil pour animaux de compagnie, du type garderie
IT1288184B1 (it) Procedimento per l'accorciamento del tempo di chiusura e dispositivo per l'attuazione del procedimento.
ITFI960030V0 (it) Tutore dinamico dell'anca,articolato e regolabile,per pazienti con difficolta' motorie
ITTO940588A0 (it) Metodo per il controllo e la guida dell'operato.
IT9021800V0 (it) Apparecchio per parrucchieri, per la rapida formazione di "meches" suicapelli
IT225672Y1 (it) Collo amovibile per protesi interna sostitutiva dell'articolazione coxo-femorale
ITBS950077A0 (it) Metodo e strumenti per la gestione della sicurezza e dell'igiene del lavoro